Last checked at 10 Nov 2017 16:04
10th November 2017
Â
N4 Pharma plc (the "Company")
Â
Notification of Transaction by Directors/PDMRs
Â
The Company was notified on 10th November 2017 that a Person Discharging Management Responsibilities ("PDMR"), had purchased shares in the Company as set out below. Following this purchase, Nigel Theobald now has a total beneficial interest in 12,255,233 Ordinary Shares, representing 16.4% of the issued share capital of the Company.
The Company's share capital consists of 74,714,285 Ordinary Shares with voting rights.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
 a) |  Name |  Nigel Theobald | |
2 | Reason for the notification | ||
 a) |  Position/status | CEO and Director | |
 b) |  Initial notification/ Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
 a) |  Name  | N4 Pharma Plc | |
 b) |  LEI | 213800I841D2RKMFK955 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
 a) |  Description of the financial instrument, type of instrument Identification code | Oridinary shares BGP 0.0004  ISIN code GB00BYW8QM32  | |
 b) |  Nature of the transaction | Direct purchase of shares | |
 c) |  Price(s) and volume(s)  | Price | volume |
£0.07925 | 56,656 | ||
d) | Aggregated information - Aggregated price - Aggregated volume - Aggregated total | n/a | |
 e) |  Date of the transaction | 10th November 2017 | |
 f) |  Place of the transaction | London Stock Exchange, AIM | |
g) | Additional Information | Â Â | |
Â